Marek Jarema

2.3k total citations
94 papers, 1.1k citations indexed

About

Marek Jarema is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Marek Jarema has authored 94 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Psychiatry and Mental health, 18 papers in Clinical Psychology and 14 papers in Cognitive Neuroscience. Recurrent topics in Marek Jarema's work include Schizophrenia research and treatment (42 papers), Bipolar Disorder and Treatment (13 papers) and Mental Health and Psychiatry (13 papers). Marek Jarema is often cited by papers focused on Schizophrenia research and treatment (42 papers), Bipolar Disorder and Treatment (13 papers) and Mental Health and Psychiatry (13 papers). Marek Jarema collaborates with scholars based in Poland, Germany and Switzerland. Marek Jarema's co-authors include Adam Wichniak, Michael J. Shapiro, Janusz Rybakowski, Aleksandra Wierzbicka, Dominika Dudek, Wojciech Jernajczyk, Antti Ahokas, Dan J. Stein, Valérie Olivier and Peter Y. Lu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemical and Biophysical Research Communications.

In The Last Decade

Marek Jarema

89 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Jarema Poland 20 395 243 203 176 164 94 1.1k
Ruth Cooper United Kingdom 16 497 1.3× 280 1.2× 189 0.9× 274 1.6× 105 0.6× 35 1.3k
Stefano Marini Italy 22 365 0.9× 294 1.2× 122 0.6× 132 0.8× 136 0.8× 67 1.2k
S. Tuinier Netherlands 21 493 1.2× 305 1.3× 94 0.5× 241 1.4× 209 1.3× 86 1.3k
Marie‐France Poirier France 17 412 1.0× 221 0.9× 112 0.6× 200 1.1× 116 0.7× 34 964
О. Гефверт Sweden 10 695 1.8× 275 1.1× 243 1.2× 172 1.0× 83 0.5× 19 1.2k
Lena Flyckt Sweden 20 608 1.5× 293 1.2× 106 0.5× 242 1.4× 167 1.0× 50 1.2k
John R. Saksa United States 14 502 1.3× 398 1.6× 226 1.1× 294 1.7× 119 0.7× 17 1.2k
George Garibaldi Switzerland 12 559 1.4× 141 0.6× 157 0.8× 164 0.9× 221 1.3× 21 1000
Agnieszka Samochowiec Poland 21 321 0.8× 288 1.2× 144 0.7× 164 0.9× 210 1.3× 86 1.2k
Adolfo Pazzagli Italy 15 314 0.8× 232 1.0× 148 0.7× 106 0.6× 66 0.4× 34 708

Countries citing papers authored by Marek Jarema

Since Specialization
Citations

This map shows the geographic impact of Marek Jarema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Jarema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Jarema more than expected).

Fields of papers citing papers by Marek Jarema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Jarema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Jarema. The network helps show where Marek Jarema may publish in the future.

Co-authorship network of co-authors of Marek Jarema

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Jarema. A scholar is included among the top collaborators of Marek Jarema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Jarema. Marek Jarema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wichniak, Adam, et al.. (2021). Treatment of insomnia – effect of trazodone and hypnotics on sleep. Psychiatria Polska. 55(4). 743–755. 17 indexed citations
2.
Jarema, Marek, et al.. (2020). From the history of Polish psychiatry: paragnomen. Psychiatria Polska. 54(6). 1255–1261.
3.
Jarema, Marek. (2018). Are we able to evaluate suicide risk?. Psychiatria Polska. 52(1). 7–19. 4 indexed citations
4.
Jarema, Marek, et al.. (2017). Paliperidone palmitate: effectiveness, safety, and the use for treatment of schizophrenia. Psychiatria Polska. 51(1). 7–21. 17 indexed citations
5.
Jakovljević, Miro, Vlado Jukić, Kaire Aadamsoo, et al.. (2016). Schizophrenia causes significant burden to patients' and caregivers' lives.. PubMed. 28(2). 104–10. 24 indexed citations
6.
Jakovljević, Miro, Vlado Jukić, Kaire Aadamsoo, et al.. (2016). Treatment patterns of schizophrenia based on the data from seven Central and Eastern European Countries.. PubMed. 28(3). 234–242. 8 indexed citations
7.
Jarema, Marek, Adam Wichniak, Dominika Dudek, et al.. (2015). Guidelines for the use of second-generation long-acting antipsychotics. Psychiatria Polska. 49(2). 225–241. 10 indexed citations
8.
Bieńkowski, Przemysław, Jerzy Samochowiec, Justyna Pełka-Wysiecka, et al.. (2014). Functional polymorphism of matrix metalloproteinase-9 (MMP9) gene is not associated with schizophrenia and with its deficit subtype. Pharmacological Reports. 67(3). 442–445. 14 indexed citations
9.
Jarema, Marek, et al.. (2014). Cognitive dysfunctions in depression – underestimated symptom or new dimension?. Psychiatria Polska. 48(6). 1105–1116. 20 indexed citations
10.
Jankowski, Konrad S., et al.. (2014). Age or age at onset? Which of them really matters for neuro and social cognition in schizophrenia?. Psychiatry Research. 225(1-2). 197–201. 32 indexed citations
11.
Stein, Dan J., Antti Ahokas, Cyril Höschl, et al.. (2014). Agomelatine in Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 75(4). 362–368. 49 indexed citations
12.
Jarema, Marek, et al.. (2014). Cognitive rehabilitation for people living with schizophrenia – the newest interventions. Psychiatria Polska. 48(6). 1179–1188. 3 indexed citations
13.
Jarema, Marek, et al.. (2013). Stigmatization on the way to recovery in mental illness. The factors directly linked to psychiatric therapy.. Psychiatria Polska. 47(6). 1011–1022. 11 indexed citations
14.
Jarema, Marek, et al.. (2011). Trazodon : lek przeciwdepresyjny : mechanizm działania i miejsce w leczeniu depresji. Jagiellonian University Repository (Jagiellonian University). 4 indexed citations
15.
Wichniak, Adam, et al.. (2011). Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone. Journal of Psychiatric Research. 45(10). 1381–1386. 57 indexed citations
16.
Jarema, Marek, et al.. (2010). Praktyczne aspekty zastosowania olanzapiny w leczeniu schizofrenii i choroby afektywnej dwubiegunowej. Psychiatria. 7(5). 180–188. 2 indexed citations
17.
Jarema, Marek, et al.. (2009). [Antipsychotics in clinical practice. Treatment of the first schizophrenic episode].. PubMed. 42(6). 841–58. 2 indexed citations
18.
Jarema, Marek, et al.. (2009). [Antipsychotics in clinical practice. The refractory schizophrenic patients treatment].. PubMed. 42(6). 859–73. 3 indexed citations
19.
Jarema, Marek. (2006). Atypical antipsychotics in the treatment of mood disorders. Current Opinion in Psychiatry. 20(1). 23–29. 19 indexed citations
20.
Jarema, Marek, Marcin Olajossy, W. Chrzanowski, et al.. (2004). [Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial].. PubMed. 37(4). 641–55. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Cooper Breakdown of academic impact, for papers by Stefano Marini Breakdown of academic impact, for papers by S. Tuinier Breakdown of academic impact, for papers by Marie‐France Poirier Breakdown of academic impact, for papers by О. Гефверт Breakdown of academic impact, for papers by Lena Flyckt Breakdown of academic impact, for papers by John R. Saksa Breakdown of academic impact, for papers by George Garibaldi Breakdown of academic impact, for papers by Agnieszka Samochowiec Breakdown of academic impact, for papers by Adolfo Pazzagli
Rankless by CCL
2026